TN HB1327 | 2017-2018 | 110th General Assembly
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 9 2017 - 25% progression, died in chamber
Action: 2017-02-17 - Assigned to s/c Insurance and Banking Subcommittee
Text: Latest bill text (Draft #1) [PDF]
Status: Introduced on February 9 2017 - 25% progression, died in chamber
Action: 2017-02-17 - Assigned to s/c Insurance and Banking Subcommittee
Text: Latest bill text (Draft #1) [PDF]
Summary
As introduced, requires certain drug manufacturers to submit information to the department of health about drug prices; requires the department of commerce and insurance to promulgate rules relating to disclosure of drug formulary prices. - Amends TCA Title 8; Title 53; Title 56; Title 63; Title 68 and Title 71.
Title
As introduced, requires certain drug manufacturers to submit information to the department of health about drug prices; requires the department of commerce and insurance to promulgate rules relating to disclosure of drug formulary prices. - Amends TCA Title 8; Title 53; Title 56; Title 63; Title 68 and Title 71.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2017-02-17 | House | Assigned to s/c Insurance and Banking Subcommittee |
| 2017-02-15 | House | P2C, ref. to Insurance and Banking Committee-- Health-- Government Operations for Review |
| 2017-02-13 | House | P1C. |
| 2017-02-09 | House | Intro. |
| 2017-02-09 | House | Filed for intro. |
Same As/Similar To
SB1423 (Crossfiled) 2017-02-13 - Passed on Second Consideration, refer to Senate Commerce and Labor Committee
